Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology
- PMID: 11709508
- PMCID: PMC1728554
- DOI: 10.1136/gut.49.6.761
Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology
Abstract
Background and aims: Cytokeratin (CK) 7 and 20 patterns are specific for long and short segments of Barrett's oesophagus but their use has not been assessed in intestinal metaplasia arising in macroscopically normal gastro-oesophageal junction (GOJ).
Patients and methods: This study was carried out in a large prospective series of 254 patients who underwent upper endoscopy, had normal gastro-oesophageal anatomy, and who had biopsies of the antrum, fundus, cardia, GOJ, and lower oesophagus. Intestinal metaplasia of the GOJ was typed by histochemistry with high iron diamine-alcian blue staining and by immunohistochemistry using CK7 and CK20 antibodies. Results were correlated with clinical, endoscopic, and pathological data.
Results: Sixty (23.6%) of our patients presenting with a normal GOJ had intestinal metaplasia. The CK7/CK20 pattern identified two groups of patients: one highly correlated with Barrett's and the other with characteristics of Helicobacter pylori gastritis. The Barrett's type CK7/CK20 pattern was related to a high frequency of gastro-oesophageal reflux symptoms (p<0.02) and normal endoscopic appearance of the stomach (p<0.03). In contrast, the gastric type CK7/CK20 pattern was linked to atrophic (p<0.02) or erythematous (p<0.05) appearance of the stomach (p<0.03), high frequency of H pylori infection (p<0.04), antral inflammation (p<0.006) with atrophy (p<0.02), and intestinal metaplasia (p<0.02).
Conclusion: In patients presenting with intestinal metaplasia in normal appearing GOJ, the cytokeratin pattern identifies two groups of patients, one with features identical to those of long segment Barrett's oesophagus and one with features seen in H pylori gastritis. These data may be used by clinicians and should result in improved endoscopic surveillance strategies targeted specifically at patients at increased risk of Barrett's oesophagus and thus cancer.
Figures


Comment in
-
The continuing tale of cytokeratins in Barrett's mucosa: as you like it.Gut. 2001 Dec;49(6):746-7. doi: 10.1136/gut.49.6.746. Gut. 2001. PMID: 11709501 Free PMC article. Review. No abstract available.
-
Cytokeratin immunoreactivity of intestinal metaplasia.Gut. 2002 Dec;51(6):894-5; author reply 895. doi: 10.1136/gut.51.6.894-a. Gut. 2002. PMID: 12427798 Free PMC article. No abstract available.
Similar articles
-
Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.Histopathology. 2005 Sep;47(3):268-75. doi: 10.1111/j.1365-2559.2005.02219.x. Histopathology. 2005. PMID: 16115227
-
Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.World J Gastroenterol. 2005 Oct 28;11(40):6360-5. doi: 10.3748/wjg.v11.i40.6360. World J Gastroenterol. 2005. PMID: 16419166 Free PMC article.
-
Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.Am J Gastroenterol. 2002 Oct;97(10):2514-23. doi: 10.1111/j.1572-0241.2002.06033.x. Am J Gastroenterol. 2002. PMID: 12385432
-
The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.Gut. 2005 Mar;54 Suppl 1(Suppl 1):i13-20. doi: 10.1136/gut.2004.041533. Gut. 2005. PMID: 15711003 Free PMC article. Review.
-
The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy.Am J Surg Pathol. 1996;20 Suppl 1:S31-50. doi: 10.1097/00000478-199600001-00005. Am J Surg Pathol. 1996. PMID: 8694147 Review.
Cited by
-
Analysis of cancer marker in tissues with Hadamard transform fluorescence spectral microscopic imaging.J Fluoresc. 2015 Mar;25(2):397-402. doi: 10.1007/s10895-015-1525-1. Epub 2015 Feb 7. J Fluoresc. 2015. PMID: 25663197
-
CDX2-induced intestinal metaplasia in human gastric organoids derived from induced pluripotent stem cells.iScience. 2022 Apr 28;25(5):104314. doi: 10.1016/j.isci.2022.104314. eCollection 2022 May 20. iScience. 2022. PMID: 35602937 Free PMC article.
-
Cytokeratins in gastroenterology. Systematic review.Prz Gastroenterol. 2015;10(2):61-70. doi: 10.5114/pg.2015.51182. Epub 2015 Jul 1. Prz Gastroenterol. 2015. PMID: 26557935 Free PMC article. Review.
-
The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?BMC Clin Pathol. 2003 Dec 2;3(1):5. doi: 10.1186/1472-6890-3-5. BMC Clin Pathol. 2003. PMID: 14651756 Free PMC article.
-
Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models.Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):3-16. doi: 10.1016/j.bpg.2014.11.001. Epub 2014 Nov 12. Best Pract Res Clin Gastroenterol. 2015. PMID: 25743452 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous